Duration of Eliquis (Apixaban) After Amputation Surgery
For VTE prophylaxis after amputation surgery, discontinue Eliquis after 7-10 days minimum, with strong consideration for extended prophylaxis up to 4 weeks if the patient has high-risk features such as cancer, restricted mobility, obesity, or history of VTE.
Evidence-Based Approach
Standard Duration: 7-10 Days Minimum
Multiple major guidelines consistently recommend at least 7-10 days of pharmacologic thromboprophylaxis after major surgery 1, 2. This represents the minimum duration for patients undergoing major surgical interventions, including amputations which carry significant VTE risk.
The FDA label for Eliquis specifies standard prophylaxis durations for major orthopedic surgery: 12 days for knee replacement and 35 days for hip replacement 3. While amputation is not specifically listed, it should be considered a major lower extremity surgery with comparable or higher VTE risk.
Extended Duration: Up to 4 Weeks for High-Risk Patients
Extended prophylaxis for 4 weeks is strongly recommended if your patient has any of the following high-risk features 1, 2:
- Cancer diagnosis (particularly if undergoing cancer-related amputation)
- Restricted mobility (highly relevant post-amputation)
- Obesity (BMI ≥30)
- History of prior VTE
- Additional risk factors (advanced age, active malignancy, prolonged immobilization)
The ACCP, ASCO, ASH, and NICE guidelines all support extended 4-week prophylaxis for high-risk surgical patients 1. The 2023 ASCO guidelines specifically state that extended prophylaxis should be offered to patients with "high-risk features, such as restricted mobility, obesity, history of VTE, or with additional risk factors" 2.
Practical Implementation Algorithm
Step 1: Assess Risk Profile
- Does the patient have cancer? → 4 weeks
- Is mobility severely restricted post-amputation? → 4 weeks
- History of VTE? → 4 weeks
- Obesity present? → 4 weeks
- Multiple moderate risk factors? → Consider 4 weeks
Step 2: If Low-Risk (No Above Features)
- Minimum duration: 7-10 days
- Consider extending to 12-14 days given the major nature of amputation surgery
Step 3: Resumption Timing Post-Surgery According to perioperative guidelines, Eliquis should be restarted 24-72 hours after surgery once adequate hemostasis is established 4. For major surgery with higher bleeding risk, wait closer to 48-72 hours 5, 6.
Critical Considerations
Bleeding Risk vs. Thrombotic Risk Balance
The French GIHP guidelines emphasize that resumption timing should account for both bleeding risk and thromboembolic risk 4. Amputation surgery typically has moderate-to-high bleeding risk, so err toward the 48-72 hour window for resumption.
Renal Function Monitoring
Monitor creatinine clearance if the amputation or patient's medical condition could affect renal function, as this impacts Eliquis dosing 4. The standard prophylactic dose is 2.5 mg twice daily 3.
Bridging Not Required
There is no need for heparin bridging when starting or stopping Eliquis in the perioperative period for most patients 4. The exception would be very high thrombotic risk patients, which should be rare.
Common Pitfalls to Avoid
Stopping too early: Don't discontinue at hospital discharge if it's before 7 days. ASH guidelines specifically recommend continuing prophylaxis post-discharge rather than stopping at discharge 1.
Ignoring mobility status: Post-amputation patients have severely restricted mobility, which is itself an indication for extended prophylaxis.
Not considering cancer: If the amputation is cancer-related, this automatically qualifies for 4-week extended prophylaxis 1, 2.
Resuming too quickly: Wait at least 24 hours, preferably 48-72 hours post-surgery before restarting to ensure adequate hemostasis 5, 6.